
    On Wednesday, May 26, 2021, the President signed into law:
H.R. 941, the "Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021," which reauthorizes stem cell programs.
  